[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

United States Aurora Kinase B Market Report 2017

December 2017 | 102 pages | ID: U8326C07D8CEN
QYResearch

US$ 3,800.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
In this report, the United States Aurora Kinase B market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
  • The West
  • Southwest
  • The Middle Atlantic
  • New England
  • The South
  • The Midwest
  • with sales (volume), revenue (value), market share and growth rate of Aurora Kinase B in these regions, from 2012 to 2022 (forecast).
United States Aurora Kinase B market competition by top manufacturers/players, with Aurora Kinase B sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
  • AbbVie Inc
  • Advenchen Laboratories LLC
  • Aeterna Zentaris Inc
  • Amgen Inc
  • AstraZeneca Plc
  • Chipscreen Biosciences Ltd
  • Cielo Therapeutics Inc
  • Sanofi
  • Sareum Holdings Plc
On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
  • AZD-2811
  • CS-2164
  • Danusertib
  • Ilorasertib
  • NMI-900
  • Others
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including
  • Anaplastic Large Cell Lymphoma
  • Kidney Cancer
  • Lung Cancer
  • Prostate Cancer
  • Others
If you have any special requirements, please let us know and we will offer you the report as you want.
United States Aurora Kinase B Market Report 2017

1 AURORA KINASE B OVERVIEW

1.1 Product Overview and Scope of Aurora Kinase B
1.2 Classification of Aurora Kinase B by Product Category
  1.2.1 United States Aurora Kinase B Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Aurora Kinase B Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 AZD-2811
  1.2.4 CS-2164
  1.2.5 Danusertib
  1.2.6 Ilorasertib
  1.2.7 NMI-900
  1.2.8 Others
1.3 United States Aurora Kinase B Market by Application/End Users
  1.3.1 United States Aurora Kinase B Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Anaplastic Large Cell Lymphoma
  1.3.3 Kidney Cancer
  1.3.4 Lung Cancer
  1.3.5 Prostate Cancer
  1.3.6 Others
1.4 United States Aurora Kinase B Market by Region
  1.4.1 United States Aurora Kinase B Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Aurora Kinase B Status and Prospect (2012-2022)
  1.4.3 Southwest Aurora Kinase B Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Aurora Kinase B Status and Prospect (2012-2022)
  1.4.5 New England Aurora Kinase B Status and Prospect (2012-2022)
  1.4.6 The South Aurora Kinase B Status and Prospect (2012-2022)
  1.4.7 The Midwest Aurora Kinase B Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Aurora Kinase B (2012-2022)
  1.5.1 United States Aurora Kinase B Sales and Growth Rate (2012-2022)
  1.5.2 United States Aurora Kinase B Revenue and Growth Rate (2012-2022)

2 UNITED STATES AURORA KINASE B MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Aurora Kinase B Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Aurora Kinase B Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Aurora Kinase B Average Price by Players/Suppliers (2012-2017)
2.4 United States Aurora Kinase B Market Competitive Situation and Trends
  2.4.1 United States Aurora Kinase B Market Concentration Rate
  2.4.2 United States Aurora Kinase B Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Aurora Kinase B Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES AURORA KINASE B SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Aurora Kinase B Sales and Market Share by Region (2012-2017)
3.2 United States Aurora Kinase B Revenue and Market Share by Region (2012-2017)
3.3 United States Aurora Kinase B Price by Region (2012-2017)

4 UNITED STATES AURORA KINASE B SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Aurora Kinase B Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Aurora Kinase B Revenue and Market Share by Type (2012-2017)
4.3 United States Aurora Kinase B Price by Type (2012-2017)
4.4 United States Aurora Kinase B Sales Growth Rate by Type (2012-2017)

5 UNITED STATES AURORA KINASE B SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Aurora Kinase B Sales and Market Share by Application (2012-2017)
5.2 United States Aurora Kinase B Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES AURORA KINASE B PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 AbbVie Inc
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Aurora Kinase B Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 AbbVie Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 Advenchen Laboratories LLC
  6.2.2 Aurora Kinase B Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 Advenchen Laboratories LLC Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Aeterna Zentaris Inc
  6.3.2 Aurora Kinase B Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Aeterna Zentaris Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Amgen Inc
  6.4.2 Aurora Kinase B Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Amgen Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 AstraZeneca Plc
  6.5.2 Aurora Kinase B Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 AstraZeneca Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Chipscreen Biosciences Ltd
  6.6.2 Aurora Kinase B Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview
6.7 Cielo Therapeutics Inc
  6.7.2 Aurora Kinase B Product Category, Application and Specification
    6.7.2.1 Product A
    6.7.2.2 Product B
  6.7.3 Cielo Therapeutics Inc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.7.4 Main Business/Business Overview
6.8 Sanofi
  6.8.2 Aurora Kinase B Product Category, Application and Specification
    6.8.2.1 Product A
    6.8.2.2 Product B
  6.8.3 Sanofi Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.8.4 Main Business/Business Overview
6.9 Sareum Holdings Plc
  6.9.2 Aurora Kinase B Product Category, Application and Specification
    6.9.2.1 Product A
    6.9.2.2 Product B
  6.9.3 Sareum Holdings Plc Aurora Kinase B Sales, Revenue, Price and Gross Margin (2012-2017)
  6.9.4 Main Business/Business Overview

7 AURORA KINASE B MANUFACTURING COST ANALYSIS

7.1 Aurora Kinase B Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Aurora Kinase B

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Aurora Kinase B Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Aurora Kinase B Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES AURORA KINASE B MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Aurora Kinase B Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Aurora Kinase B Sales Volume Forecast by Type (2017-2022)
11.3 United States Aurora Kinase B Sales Volume Forecast by Application (2017-2022)
11.4 United States Aurora Kinase B Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.
LIST OF TABLES AND FIGURES

Figure Product Picture of Aurora Kinase B
Figure United States Aurora Kinase B Market Size (K Pcs) by Type (2012-2022)
Figure United States Aurora Kinase B Sales Volume Market Share by Type (Product Category) in 2016
Figure AZD-2811 Product Picture
Figure CS-2164 Product Picture
Figure Danusertib Product Picture
Figure Ilorasertib Product Picture
Figure NMI-900 Product Picture
Figure Others Product Picture
Figure United States Aurora Kinase B Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Aurora Kinase B by Application in 2016
Figure Anaplastic Large Cell Lymphoma Examples
Table Key Downstream Customer in Anaplastic Large Cell Lymphoma
Figure Kidney Cancer Examples
Table Key Downstream Customer in Kidney Cancer
Figure Lung Cancer Examples
Table Key Downstream Customer in Lung Cancer
Figure Prostate Cancer Examples
Table Key Downstream Customer in Prostate Cancer
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Aurora Kinase B Market Size (Million USD) by Region (2012-2022)
Figure The West Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Aurora Kinase B Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Aurora Kinase B Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Aurora Kinase B Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Aurora Kinase B Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Aurora Kinase B Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Aurora Kinase B Sales Share by Players/Suppliers
Figure 2017 United States Aurora Kinase B Sales Share by Players/Suppliers
Figure United States Aurora Kinase B Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Aurora Kinase B Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Aurora Kinase B Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Aurora Kinase B Revenue Share by Players/Suppliers
Figure 2017 United States Aurora Kinase B Revenue Share by Players/Suppliers
Table United States Market Aurora Kinase B Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Aurora Kinase B Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Aurora Kinase B Market Share of Top 3 Players/Suppliers
Figure United States Aurora Kinase B Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Aurora Kinase B Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Aurora Kinase B Product Category
Table United States Aurora Kinase B Sales (K Pcs) by Region (2012-2017)
Table United States Aurora Kinase B Sales Share by Region (2012-2017)
Figure United States Aurora Kinase B Sales Share by Region (2012-2017)
Figure United States Aurora Kinase B Sales Market Share by Region in 2016
Table United States Aurora Kinase B Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Aurora Kinase B Revenue Share by Region (2012-2017)
Figure United States Aurora Kinase B Revenue Market Share by Region (2012-2017)
Figure United States Aurora Kinase B Revenue Market Share by Region in 2016
Table United States Aurora Kinase B Price (USD/Pcs) by Region (2012-2017)
Table United States Aurora Kinase B Sales (K Pcs) by Type (2012-2017)
Table United States Aurora Kinase B Sales Share by Type (2012-2017)
Figure United States Aurora Kinase B Sales Share by Type (2012-2017)
Figure United States Aurora Kinase B Sales Market Share by Type in 2016
Table United States Aurora Kinase B Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Aurora Kinase B Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase B by Type (2012-2017)
Figure Revenue Market Share of Aurora Kinase B by Type in 2016
Table United States Aurora Kinase B Price (USD/Pcs) by Types (2012-2017)
Figure United States Aurora Kinase B Sales Growth Rate by Type (2012-2017)
Table United States Aurora Kinase B Sales (K Pcs) by Application (2012-2017)
Table United States Aurora Kinase B Sales Market Share by Application (2012-2017)
Figure United States Aurora Kinase B Sales Market Share by Application (2012-2017)
Figure United States Aurora Kinase B Sales Market Share by Application in 2016
Table United States Aurora Kinase B Sales Growth Rate by Application (2012-2017)
Figure United States Aurora Kinase B Sales Growth Rate by Application (2012-2017)
Table AbbVie Inc Basic Information List
Table AbbVie Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AbbVie Inc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure AbbVie Inc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure AbbVie Inc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Advenchen Laboratories LLC Basic Information List
Table Advenchen Laboratories LLC Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Advenchen Laboratories LLC Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Aeterna Zentaris Inc Basic Information List
Table Aeterna Zentaris Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Aeterna Zentaris Inc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Amgen Inc Basic Information List
Table Amgen Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Amgen Inc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Amgen Inc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Amgen Inc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table AstraZeneca Plc Basic Information List
Table AstraZeneca Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure AstraZeneca Plc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Chipscreen Biosciences Ltd Basic Information List
Table Chipscreen Biosciences Ltd Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Chipscreen Biosciences Ltd Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Cielo Therapeutics Inc Basic Information List
Table Cielo Therapeutics Inc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Cielo Therapeutics Inc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Sanofi Basic Information List
Table Sanofi Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sanofi Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Sanofi Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Sanofi Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Sareum Holdings Plc Basic Information List
Table Sareum Holdings Plc Aurora Kinase B Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Sales Growth Rate (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Sales Market Share in United States (2012-2017)
Figure Sareum Holdings Plc Aurora Kinase B Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Aurora Kinase B
Figure Manufacturing Process Analysis of Aurora Kinase B
Figure Aurora Kinase B Industrial Chain Analysis
Table Raw Materials Sources of Aurora Kinase B Major Players/Suppliers in 2016
Table Major Buyers of Aurora Kinase B
Table Distributors/Traders List
Figure United States Aurora Kinase B Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Aurora Kinase B Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Aurora Kinase B Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Aurora Kinase B Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Aurora Kinase B Sales Volume Share Forecast by Region (2017-2022)
Figure United States Aurora Kinase B Sales Volume Share Forecast by Region (2017-2022)
Figure United States Aurora Kinase B Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources


More Publications